Sign in
WVE Stock Price, Chart, Stats & News
Wave Life Sciences Ltd.
Save
1.19B
Market cap
–
Current P/E
–
Forward P/E
WVE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 84.50% |
Operating margin | -504.09% |
Pretax margin | -478.33% |
Net margin | -478.33% |
Effective tax rate | – |
ROA | -32.01% |
ROE | -84.99% |
D/E | 0.03x |
Interest coverage ratio | – |
WVE valuation
P/E | – |
P/S | 28.04x |
P/B | 2.18x |
P/CF | -6.17x |
P/FCF | -6.42x |
P/OCF | -6.17x |
PEG | 0.09x |
EV multiple | -8.88x |
About
Wave Life Sciences Ltd. (WVE) is a clinical-stage genetic medicine firm dedicated to inventing, refining, and manufacturing novel stereopure oligonucleotide therapies. The company utilizes its proprietary PRISM platform for discovery and drug development. These specialized oligonucleotides are designed to interact with ribonucleic acid (RNA) to precisely modulate protein expression within the body.
Similar securities
Based on sector and market capitalization
Report issue